Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Recipient : Universitat de Lleida
Deal Size : Inapplicable
Deal Type : Inapplicable
ABG+/GarlACE Effects on Cardiovascular Risk Factors in Subjects With Grade I Hypertension
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 20, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Recipient : Universitat de Lleida
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Saffron Extract
Therapeutic Area : Ophthalmology
Study Phase : Undisclosed
Recipient : University of Alicante
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
February 05, 2024
Lead Product(s) : Saffron Extract
Therapeutic Area : Ophthalmology
Highest Development Status : Undisclosed
Recipient : University of Alicante
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Saffron Extract
Therapeutic Area : Ophthalmology
Study Phase : Undisclosed
Recipient : University of Alicante
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of CROCUVIS+® on Computer Vision Syndrome, Sleep and Mood Disorders
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
January 27, 2022
Lead Product(s) : Saffron Extract
Therapeutic Area : Ophthalmology
Highest Development Status : Undisclosed
Recipient : University of Alicante
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Abg+ Black Garlin
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Recipient : Universitat de Lleida
Deal Size : Inapplicable
Deal Type : Inapplicable
Black Garlic Nutraceuticals and Blood Pressure Control
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
June 07, 2021
Lead Product(s) : Abg+ Black Garlin
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Recipient : Universitat de Lleida
Deal Size : Inapplicable
Deal Type : Inapplicable